| Präparat | Galenische Form | Stärke | Packungsgrösse | PP | SB | Zulassungsinh. | | Betäubungsmittel | | | |
|---|
|
| Dezember 2010 - 123 Präparate |
|
| Atorvastatin Pfizer 10 mg | Filmtabletten | 10 mg | 30 Tablette(n) | 61.05 | 10% | Pfizer AG | | | | FI | PI |
| Atorvastatin Pfizer 10 mg | Filmtabletten | 10 mg | 100 Tablette(n) | 163.25 | 10% | Pfizer AG | | | | FI | PI |
| Atorvastatin Pfizer 20 mg | Filmtabletten | 20 mg | 30 Tablette(n) | 61.05 | 10% | Pfizer AG | | | | FI | PI |
| Atorvastatin Pfizer 20 mg | Filmtabletten | 20 mg | 100 Tablette(n) | 163.25 | 10% | Pfizer AG | | | | FI | PI |
| Atorvastatin Pfizer 40 mg | Filmtabletten | 40 mg | 30 Tablette(n) | 61.05 | 10% | Pfizer AG | | | | FI | PI |
| Atorvastatin Pfizer 40 mg | Filmtabletten | 40 mg | 100 Tablette(n) | 163.25 | 10% | Pfizer AG | | | | FI | PI |
| Atorvastatin Pfizer 80 mg | Filmtabletten | 80 mg | 30 Tablette(n) | 61.05 | 10% | Pfizer AG | | | | FI | PI |
| Atorvastatin Pfizer 80 mg | Filmtabletten | 80 mg | 100 Tablette(n) | 163.25 | 10% | Pfizer AG | | | | FI | PI |
| Co-Latanoprost Pfizer | Augentropfen | 5050 µg/ml | 2.5 ml | 39.60 | 10% | Pfizer AG | | | | FI | PI |
| Co-Latanoprost Pfizer | Augentropfen | 5050 µg/ml | 3 x 2.5 ml | 84.60 | 10% | Pfizer AG | | | | FI | PI |
Co-Valsartan Sandoz 160/12.5 | Filmtabletten | 172.5 mg | 28 Tablette(n) | 26.20 | 10% | Sandoz Pharmaceuticals AG | | | | FI | PI |
Co-Valsartan Sandoz 160/12.5 | Filmtabletten | 172.5 mg | 98 Tablette(n) | 64.95 | 10% | Sandoz Pharmaceuticals AG | | | | FI | PI |
Co-Valsartan Sandoz 160/25 | Filmtabletten | 185 mg | 28 Tablette(n) | 26.20 | 10% | Sandoz Pharmaceuticals AG | | | | FI | PI |
Co-Valsartan Sandoz 160/25 | Filmtabletten | 185 mg | 98 Tablette(n) | 64.95 | 10% | Sandoz Pharmaceuticals AG | | | | FI | PI |
Co-Valsartan Sandoz 80/12.5 | Filmtabletten | 92.5 mg | 28 Tablette(n) | 19.90 | 10% | Sandoz Pharmaceuticals AG | | | | FI | PI |
Co-Valsartan Sandoz 80/12.5 | Filmtabletten | 92.5 mg | 98 Tablette(n) | 54.20 | 10% | Sandoz Pharmaceuticals AG | | | | FI | PI |
Gemcitabin Sandoz 1000mg / 100ml | Infusionslösung | 1000mg / 100ml | Durchstechflasche(n) | 164.70 | 10% | Sandoz Pharmaceuticals AG | | | | FI | |
Gemcitabin Sandoz 200mg / 20ml | Infusionslösung | 200mg / 20ml | Durchstechflasche(n) | 46.25 | 10% | Sandoz Pharmaceuticals AG | | | | FI | |
Gemcitabin Sandoz 500mg / 50ml | Infusionslösung | 500mg / 50ml | Durchstechflasche(n) | 91.00 | 10% | Sandoz Pharmaceuticals AG | | | | FI | |
| Letrozol Orion | Filmtabletten | 2.5 mg | 30 Tablette(n) | 96.00 | 10% | Orion Pharma AG | | | | | |
| Letrozol Orion | Filmtabletten | 2.5 mg | 100 Tablette(n) | 280.40 | 10% | Orion Pharma AG | | | | | |
| Methylprednisolon-Teva 1 g | Pulver für Injektionslösung | 1000 mg | Ampulle(n) | 68.25 | 10% | Teva Pharma AG | | | | FI | |
| Methylprednisolon-Teva 125 mg | Pulver für Injektionslösung | 125 mg | Ampulle(n) | 15.60 | 10% | Teva Pharma AG | | | | FI | |
| Methylprednisolon-Teva 40 mg | Pulver für Injektionslösung | 40 mg | Ampulle(n) | 9.60 | 10% | Teva Pharma AG | | | | FI | |
| Methylprednisolon-Teva 500 mg | Pulver für Injektionslösung | 500 mg | Ampulle(n) | 44.15 | 10% | Teva Pharma AG | | | | FI | |
Piperacilline-Tazobactam Labatec i.v. 2 g - 0,25 g | poudre pour solution pour injection ou pour perfusion | 2.25 g | | PA | 10% | Labatec Pharma SA | | | | | |
Piperacilline-Tazobactam Labatec i.v. 4 g - 0,5 g | poudre pour solution pour injection ou pour perfusion | 4.5 g | | PA | 10% | Labatec Pharma SA | | | | | |
| Vancomycin Pfizer i.v. 1 g | Lyophilisat | 1 g | 1 g | 42.80 | 10% | Pfizer AG | | | | FI | |
| Vancomycin Pfizer i.v. 500 mg | Lyophilisat | 500 mg | 500 mg | 25.50 | 10% | Pfizer AG | | | | FI | |
| Alprazolam Pfizer 0.25 mg | Tabletten | 0.25 mg | 30 Tablette(n) | 6.90 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer 0.25 mg | Tabletten | 0.25 mg | 100 Tablette(n) | 15.85 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer 0.5 mg | Tabletten | 0.5 mg | 30 Tablette(n) | 8.55 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer 0.5 mg | Tabletten | 0.5 mg | 100 Tablette(n) | 20.75 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer 1.0 mg | Tabletten | 1 mg | 30 Tablette(n) | 16.15 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer 1.0 mg | Tabletten | 1 mg | 100 Tablette(n) | 37.45 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer 2.0 mg | Tabletten | 2 mg | 30 Tablette(n) | 28.25 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer 2.0 mg | Tabletten | 2 mg | 100 Tablette(n) | 59.55 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer retard 0.5 mg | Tabletten | 0.5 mg | 30 Tablette(n) | 8.55 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer retard 0.5 mg | Tabletten | 0.5 mg | 100 Tablette(n) | 20.75 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer retard 1 mg | Tabletten | 1 mg | 30 Tablette(n) | 16.15 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer retard 1 mg | Tabletten | 1 mg | 100 Tablette(n) | 37.45 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer retard 2 mg | Tabletten | 2 mg | 30 Tablette(n) | 28.25 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer retard 2 mg | Tabletten | 2 mg | 100 Tablette(n) | 59.55 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer retard 3 mg | Tabletten | 3 mg | 30 Tablette(n) | 38.15 | k.A. | Pfizer AG | | BM | | FI | PI |
| Alprazolam Pfizer retard 3 mg | Tabletten | 3 mg | 100 Tablette(n) | 80.40 | k.A. | Pfizer AG | | BM | | FI | PI |
| Arbid N | gouttes à avaler | 2 mg/g | 30 ml | PA | k.A. | Vifor SA | | | | | |
| Atorsan 10 mg | Filmtabletten | 10 mg | 30 Tablette(n) | PA | k.A. | Sandoz Pharmaceuticals AG | | | | | |
| Atorsan 10 mg | Filmtabletten | 10 mg | 100 Tablette(n) | PA | k.A. | Sandoz Pharmaceuticals AG | | | | | |
| Atorsan 20 mg | Filmtabletten | 20 mg | 30 Tablette(n) | PA | k.A. | Sandoz Pharmaceuticals AG | | | | | |
| Atorsan 20 mg | Filmtabletten | 20 mg | 100 Tablette(n) | PA | k.A. | Sandoz Pharmaceuticals AG | | | | | |
| Atorsan 40 mg | Filmtabletten | 40 mg | 30 Tablette(n) | PA | k.A. | Sandoz Pharmaceuticals AG | | | | | |
| Atorsan 40 mg | Filmtabletten | 40 mg | 100 Tablette(n) | PA | k.A. | Sandoz Pharmaceuticals AG | | | | | |
| Atorsan 80 mg | Filmtabletten | 80 mg | 30 Tablette(n) | PA | k.A. | Sandoz Pharmaceuticals AG | | | | | |
| Atorsan 80 mg | Filmtabletten | 80 mg | 100 Tablette(n) | PA | k.A. | Sandoz Pharmaceuticals AG | | | | | |
Cayston, Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler (mit Altera-Vernebler) | Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler (mit Altera-Vernebler) | 75 mg/ml | 84 + 88 | PA | k.A. | Gilead Sciences Switzerland Sàrl | | | | | |
| Cefuroxim Labatec i.v. 1,5 g | poudre pour la préparation d'une solution injectable ou pour perfusion | 1.5 g | 1.5 g | PA | k.A. | Labatec Pharma SA | | | | | |
| Cefuroxim Labatec i.v. 1,5 g | poudre pour la préparation d'une solution injectable ou pour perfusion | 1.5 g | 1.5 g | PA | k.A. | Labatec Pharma SA | | | | | |
| Cefuroxim Labatec i.v. 750 mg | poudre pour la préparation d'une solution injectable | 750 mg | 750 mg | PA | k.A. | Labatec Pharma SA | | | | | |
| Clarelux | Schaum zur Anwendung auf der Haut | 0.5 mg/g | 50 g | 17.40 | 10% | Pierre Fabre (Suisse) S.A. | | | | | |
| Clarelux | Schaum zur Anwendung auf der Haut | 0.5 mg/g | 100 g | 34.80 | 10% | Pierre Fabre (Suisse) S.A. | | | | | |
| Codicalm | Sirup | 5mg / 5ml | 200 ml | PA | k.A. | Dr. Heinz Welti AG | | | | | |
Compressi Harpagophyti Radix | Tabletten | 182.36 mg | 250 Tablette(n) | PA | k.A. | Dixa AG | | | Ph | | |
| Diaphin IR 200 | Tabletten | 182 mg | 100 Tablette(n) | PA | k.A. | DiaMo Narcotics GmbH | | BM | | | PI |
| Diaphin SR 200 | Filmtabletten | 182 mg | 100 Tablette(n) | PA | k.A. | DiaMo Narcotics GmbH | | BM | | | PI |
| Donepezil OrPha 10 mg | Filmtabletten | 10 mg | 28 Tablette(n) | PA | k.A. | OrPha Swiss GmbH | | | | | |
| Donepezil OrPha 10 mg | Filmtabletten | 10 mg | 50 Tablette(n) | PA | k.A. | OrPha Swiss GmbH | | | | | |
| Donepezil OrPha 10 mg | Filmtabletten | 10 mg | 98 Tablette(n) | PA | k.A. | OrPha Swiss GmbH | | | | | |
| Donepezil OrPha 5 mg | Filmtabletten | 5 mg | 28 Tablette(n) | PA | k.A. | OrPha Swiss GmbH | | | | | |
| Donepezil OrPha 5 mg | Filmtabletten | 5 mg | 50 Tablette(n) | PA | k.A. | OrPha Swiss GmbH | | | | | |
| Donepezil OrPha 5 mg | Filmtabletten | 5 mg | 98 Tablette(n) | PA | k.A. | OrPha Swiss GmbH | | | | | |
Heidak Spagyrik Halsschmerzen | Spray | | 50 ml | PA | k.A. | Heidak AG, Emmenbrücke | | | H | | |
| Lamotrigine Rivopharm 100 mg | compresse dispersibili | 100 mg | 56 Tablette(n) | PA | k.A. | Rivopharm SA | | | | | |
| Lamotrigine Rivopharm 2 mg | compresse dispersibili | 2 mg | 30 Tablette(n) | PA | k.A. | Rivopharm SA | | | | | |
| Lamotrigine Rivopharm 200 mg | compresse dispersibili | 200 mg | 56 Tablette(n) | PA | k.A. | Rivopharm SA | | | | | |
| Lamotrigine Rivopharm 25 mg | compresse dispersibili | 25 mg | 56 Tablette(n) | PA | k.A. | Rivopharm SA | | | | | |
| Lamotrigine Rivopharm 5 mg | compresse dispersibili | 5 mg | 56 Tablette(n) | PA | k.A. | Rivopharm SA | | | | | |
| Lamotrigine Rivopharm 50 mg | compresse dispersibili | 50 mg | 56 Tablette(n) | PA | k.A. | Rivopharm SA | | | | | |
| Letrozol OrPha | Filmtabletten | 2.5 mg | 30 Tablette(n) | PA | k.A. | OrPha Swiss GmbH | | | | | |
| Letrozol OrPha | Filmtabletten | 2.5 mg | 100 Tablette(n) | PA | k.A. | OrPha Swiss GmbH | | | | | |
| Neurexan | Tropfen | | 30 ml | PA | k.A. | Ebi-Pharm AG | | | H | | PI |
Nutriflex Omega plus, Infusionsemulsion 1250 ml | Infusionsemulsion | 0.61413 g/ml | 5 1 Sachet(s) à 1250 ml | PA | k.A. | B. Braun Medical AG | | | | | |
Nutriflex Omega plus, Infusionsemulsion 1875 ml | Infusionsemulsion | 0.61415 g/ml | 5 1 Sachet(s) à 1875 ml | PA | k.A. | B. Braun Medical AG | | | | | |
Nutriflex Omega plus, Infusionsemulsion 2500 ml | Infusionsemulsion | 0.61413 g/ml | 5 1 Sachet(s) à 2500 ml | PA | k.A. | B. Braun Medical AG | | | | | |
Nutriflex Omega special, Infusionsemulsion 1250 ml | Infusionsemulsion | 0.72401 g/ml | 5 1 Sachet(s) à 1250 ml | PA | k.A. | B. Braun Medical AG | | | | | |
Nutriflex Omega special, Infusionsemulsion 1875 ml | Infusionsemulsion | 0.72395 g/ml | 5 1 Sachet(s) à 1875 ml | PA | k.A. | B. Braun Medical AG | | | | | |
Nutriflex Omega special, Infusionsemulsion 2500 ml | Infusionsemulsion | 0.72393 g/ml | 5 1 Sachet(s) à 2500 ml | PA | k.A. | B. Braun Medical AG | | | | | |
Nutriflex Omega special, Infusionsemulsion 625 ml | Infusionsemulsion | 0.72422 g/ml | 5 1 Sachet(s) à 625 ml | PA | k.A. | B. Braun Medical AG | | | | | |
| Olanzapin Helvepharm 10 mg | Schmelztabletten | 10 mg | 28 Tablette(n) | PA | k.A. | Helvepharm AG | | | | | |
| Olanzapin Helvepharm 10 mg | Tabletten | 10 mg | 28 Tablette(n) | PA | k.A. | Helvepharm AG | | | | | |
| Olanzapin Helvepharm 15 mg | Schmelztabletten | 15 mg | 28 Tablette(n) | PA | k.A. | Helvepharm AG | | | | | |
| Olanzapin Helvepharm 15 mg | Tabletten | 15 mg | 28 Tablette(n) | PA | k.A. | Helvepharm AG | | | | | |
| Olanzapin Helvepharm 2.5 mg | Tabletten | 2.5 mg | 28 Tablette(n) | PA | k.A. | Helvepharm AG | | | | | |
| Olanzapin Helvepharm 20 mg | Schmelztabletten | 20 mg | 28 Tablette(n) | PA | k.A. | Helvepharm AG | | | | | |
| Olanzapin Helvepharm 20 mg | Tabletten | 20 mg | 28 Tablette(n) | PA | k.A. | Helvepharm AG | | | | | |
| Olanzapin Helvepharm 5 mg | Schmelztabletten | 5 mg | 28 Tablette(n) | PA | k.A. | Helvepharm AG | | | | | |
| Olanzapin Helvepharm 5 mg | Tabletten | 5 mg | 28 Tablette(n) | PA | k.A. | Helvepharm AG | | | | | |
Omeprazol Axapharm 20 mg, Kapseln | Kapseln | 20 mg | 7 Kapsel(n) | PA | k.A. | Axapharm AG | | | | | |
Omeprazol Axapharm 20 mg, Kapseln | Kapseln | 20 mg | 14 Kapsel(n) | PA | k.A. | Axapharm AG | | | | | |
Omeprazol Axapharm 20 mg, Kapseln | Kapseln | 20 mg | 28 Kapsel(n) | PA | k.A. | Axapharm AG | | | | | |
Omeprazol Axapharm 20 mg, Kapseln | Kapseln | 20 mg | 56 Kapsel(n) | PA | k.A. | Axapharm AG | | | | | |
Omeprazol Axapharm 20 mg, Kapseln | Kapseln | 20 mg | 98 Kapsel(n) | PA | k.A. | Axapharm AG | | | | | |
Omeprazol Axapharm 40 mg, Kapseln | Kapseln | 40 mg | 7 Kapsel(n) | PA | k.A. | Axapharm AG | | | | | |
Omeprazol Axapharm 40 mg, Kapseln | Kapseln | 40 mg | 28 Kapsel(n) | PA | k.A. | Axapharm AG | | | | | |
Omeprazol Axapharm 40 mg, Kapseln | Kapseln | 40 mg | 56 Kapsel(n) | PA | k.A. | Axapharm AG | | | | | |
Omeprazol Axapharm 40 mg, Kapseln | Kapseln | 40 mg | 98 Kapsel(n) | PA | k.A. | Axapharm AG | | | | | |
| Qutenza | kutanes Pflaster | 179mg / 2.24g | Pflaster | 428.50 | 10% | Astellas Pharma AG | L | | | | |
| Qutenza | kutanes Pflaster | 179mg / 2.24g | 2 Pflaster | PA | k.A. | Astellas Pharma AG | | | | | |
Saizen Liquid 12 mg (8 mg/ml) | Injektionslösung | 12mg / 1.5ml | Zylinderampulle(n) | 795.45 | 10% | Merck (Schweiz) AG | L | | | FI | PI |
Saizen Liquid 20 mg (8 mg/ml) | Injektionslösung | 20mg / 2.5ml | Zylinderampulle(n) | 1301.90 | 10% | Merck (Schweiz) AG | L | | | FI | PI |
Saizen Liquid 6 mg (5.83 mg/ml) | Injektionslösung | 6mg / 1.03ml | Zylinderampulle(n) | 405.90 | 10% | Merck (Schweiz) AG | L | | | FI | PI |
| Solaraze 3% | Gel | 30 mg/g | 25 g | 51.30 | 10% | Almirall AG | | | | FI | |
| Solaraze 3% | Gel | 30 mg/g | 50 g | 77.80 | 10% | Almirall AG | | | | FI | |
| Solaraze 3% | Gel | 30 mg/g | 100 g | PA | k.A. | Almirall AG | | | | FI | |
| Vantas 50 mg | Implantat | 46.72mg / 2ml | Set(s) | 1999.40 | 10% | Orion Pharma AG | | | | FI | |
| Xeplion 100 mg | Retardsuspension zur intramuskulären Injektion | 100mg / 100mg | Spritze(n) | 705.85 | 10% | Janssen-Cilag AG | | | | FI | |
| Xeplion 150 mg | Retardsuspension zur intramuskulären Injektion | 150mg / 1.5ml | Spritze(n) | 877.15 | 10% | Janssen-Cilag AG | | | | FI | |
| Xeplion 25 mg | Retardsuspension zur intramuskulären Injektion | 25 mg/ml | Spritze(n) | 263.75 | 10% | Janssen-Cilag AG | | | | FI | |
| Xeplion 50 mg | Retardsuspension zur intramuskulären Injektion | 50 mg/ml | Spritze(n) | 422.05 | 10% | Janssen-Cilag AG | | | | FI | |
| Xeplion 75 mg | Retardsuspension zur intramuskulären Injektion | 75 mg/ml | Spritze(n) | 579.30 | 10% | Janssen-Cilag AG | | | | FI | |
| multiLac 2 mmol/L Kalium | Hämofiltrationslösung | | 2 x 5000 ml | PA | k.A. | Fresenius Medical Care (Schweiz) AG | | | | FI | |
| multiLac 3 mmol/L Kalium | Hämofiltrationslösung | 292 mmol/l | 2 x 5000 ml | PA | k.A. | Fresenius Medical Care (Schweiz) AG | | | | FI | |
| multiLac 4 mmol/L Kalium | Hämofiltrationslösung | 294 mmol/l | 2 x 5000 ml | PA | k.A. | Fresenius Medical Care (Schweiz) AG | | | | FI | |
| multiLac kaliumfrei | Hämofiltrationslösung | | 2 x 5000 ml | PA | k.A. | Fresenius Medical Care (Schweiz) AG | | | | FI | |